Analyst Price Targets — EVOK
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| October 28, 2024 2:21 pm | Yale Jen | Laidlaw | $18.00 | $7.08 | StreetInsider | Laidlaw Reiterates Buy Rating on Evoke Pharma (EVOK) |
Latest News for EVOK
William Hill owner Evoke in talks with Ball's Intralot about potential takeover
William Hill owner Evoke PLC (LSE:EVOK) has confirmed it is in talks about being taken over by Greek-US lottery and gambling outfit Bally's Intralot. The bookmaker said a proposed offer valuing the group at 50p per share is being discussed, via an all-share combination, alongside a partial cash alternative.
William Hill UK owner Evoke confirms $304 million takeover bid from Bally's Intralot
William Hill UK and 888 owner Evoke confirmed on Monday that it is in talks with Greek lottery and gaming firm Bally's Intralot regarding a takeover proposal at 50 pence-per-share, valuing the betting group at 225.3 million pounds ($303.88 million).
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for EVOK.
U.S. House Trading
No House trades found for EVOK.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.